Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Women seem to be more susceptible to the harmful effects of smoking than their male counterparts, according to findings from a case-control study…
Stuart Fischer, MD, discusses how physicians can help patients by adopting lifestyle adjustments. Recommending a diet is not enough. It requires a comprehensive lifestyle approach. Diets alone just…
David Kloth, MD, is the Founder, President and Medical Director of Connecticut Pain Care, P.C., a pain management center for the treatment of acute and chronic pain. He…
B. Todd Schaeffer, MD, FACS reviews FinESS, a novel minimally invasive sinus treatment, which is being used as an alternative to more traditional sinus surgery. References and Resources…
David Kloth, MD, is the Founder, President and Medical Director of Connecticut Pain Care, P.C., a pain management center for the treatment of acute and chronic pain. He…
NEW YORK (Reuters Health) – The earlier the Kasai operation is performed to bypass extrahepatic bile ducts in cases of biliary atresia, the better is the long-term outcome,…
NEW YORK (Reuters Health) – In cancer patients accidentally overexposed with 5-fluorouracil (5-FU) chemotherapy, the investigational drug vistonuridine (Wellstat Therapeutics Corp) may be lifesaving, according to research to…
NEW YORK (Reuters Health) – New research suggests that many patients with sleep apnea continue to experience excessive daytime sleepiness despite treatment with continuous positive airway pressure (CPAP).…
Kim Hunter-Schaedle, PhD, Chief Scientific Officer of the Children’s Tumor Foundation, discusses Neurofibromatosis, a complex disorder that affects 1 in 3000 children, making it more common than better…
NEW YORK (Reuters Health) – New research suggests that spinal fluid levels of three biomarkers may help identify people with very mild dementia of the Alzheimer type (DAT)…
